Provided by Tiger Trade Technology Pte. Ltd.

Silexion Therapeutics Corp

0.2146
-0.0203-8.64%
Post-market: 0.2097-0.0049-2.28%19:57 EDT
Volume:821.09K
Turnover:181.89K
Market Cap:3.11M
PE:0.00
High:0.2320
Open:0.2297
Low:0.2079
Close:0.2349
52wk High:40.70
52wk Low:0.2079
Shares:14.47M
Float Shares:14.47M
Volume Ratio:0.60
T/O Rate:5.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-56.4473
EPS(LYR):-89.5962
ROE:-897.46%
ROA:-123.27%
PB:70.59
PE(LYR):0.00

Loading ...

Apr 01, 2025

Correspondence

Form CORRESP - Correspondence
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 12, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Major Issues Report

Form 8-K - Current report